Methylphenidate for ADHD in Pediatric Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.
Who Is on the Research Team?
Jay Salpekar, MD
Principal Investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Are You a Good Fit for This Trial?
This trial is for children who have both epilepsy (controlled with medication) and ADHD that affects their daily life. They must be in good overall health, not have had recent severe seizures, and have a caregiver able to help monitor their treatment.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive open-label flexible dose of stimulant medication for ADHD
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- methylphenidate hydrochloride (Jornay PM)
Trial Overview
The study observes how the ADHD medication methylphenidate hydrochloride (Jornay PM) works and is tolerated in kids with epilepsy who are already taking anti-seizure medicine.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
open label flexible dose
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.